Abstract
Several cases of sarcoidosis following treatment with interferon-α have been reported in the literature, but those following interferon-β are very rare. We report the case of a patient with multiple sclerosis who developed pulmonary and cutaneous sarcoidosis following treatment with Betaseron® (interferon-β-1b). A 33-year-old Caucasian woman with a history of multiple sclerosis, treated with interferon-β-1b for 2.5 years developed erythema nodosum in her lower limbs, a breast abscess, and unilateral adenopathy of her left lung. A skin biopsy confirmed sarcoidosis. After the discontinuation of interferon-β-1b and treatment with indomethacin and prednisolone, she recovered. Sarcoidosis is considered one of the most common multiple sclerosis imitators with involvement of the central nervous system. However, although rare, sarcoidosis can develop following treatment with interferon-β-1b and should be considered in patients with multiple sclerosis treated with beta-interferons who develop pulmonary or extra-pulmonary manifestations of sarcoidosis. Interferon-β-1b discontinuation is the first and most important step in the treatment of such cases followed by treatment with corticosteroids.
References
Mar 1, 1978·Archives of Internal Medicine·A Sybert, T P Butler
Mar 1, 1987·Cancer·E A AbdiW J Dickout
Jul 1, 1996·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·A Zumla, D G James
Oct 8, 1998·The European Respiratory Journal·J Müller-Quernheim
Dec 8, 1998·Journal of the American Academy of Dermatology·C L MehtaD J Cripps
Feb 3, 2006·International Journal of Clinical Practice·S Alazemi, M A Campos
Sep 26, 2007·Annals of the New York Academy of Sciences·Uriel KatzPnina Langevitz
Dec 15, 2010·The Neurologist·Thomas F ScottCarol Schramke
May 11, 2012·Seminars in Arthritis and Rheumatism·Soumya D ChakravartyMary K Crow
Oct 10, 2012·Journal of Medical Case Reports·Nayia Petousi, Enson C Thomas
Oct 30, 2012·Immunology and Allergy Clinics of North America·Daniel A Culver
Nov 2, 2012·Current Opinion in Rheumatology·Roberto Perez-AlvarezUNKNOWN BIOGEAS study group
Apr 12, 2013·BMJ Case Reports·Monica GuptaMala Bhalla